Status:
COMPLETED
VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis
Lead Sponsor:
Bayer
Conditions:
Chronic Bronchitis
Disease Exacerbation
Eligibility:
All Genders
18+ years
Brief Summary
This study is a local, prospective, open-label, company-sponsored, non interventional, multi-center study. Patients documented must suffer from an acute exacerbation of chronic bronchitis and take at ...
Eligibility Criteria
Inclusion
- Patients at least 18 years of age with a diagnosis of AECB treated with Moxifloxacin injection with/without sequential tablet treatment
Exclusion
- Exclusion criteria must be read in conjunction with the local product information
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
1206 Patients enrolled
Trial Details
Trial ID
NCT00876577
Start Date
May 1 2009
End Date
March 1 2011
Last Update
September 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, China